The expert medical director at Roche provided detail on results from the phase 2 PASADENA study presented at the 2021 MDS Virtual Congress. [WATCH TIME: 3 minutes]
Gennero Pagano, MD, MSc, PhD
Advertisement
Articles by Gennero Pagano, MD, MSc, PhD
Advertisement
Latest Updated Articles
Positive Signs From Prasinezumab in Parkinson Disease: Gennero Pagano, MD, MSc, PhDPublished: October 1st 2021 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
NeurologyLive® Brain Games: October 26, 2025
2
Incidence and Prevalence of Frontotemporal Dementia Similar to Dementia with Lewy Bodies, Meta-Analysis Shows
3
FDA Fast Tracks Etalanetug, Encouraging Interim TEMPO-4 Data, Initial Data on Cell Therapy UX-DA001
4
Enhancing Stroke Systems of Care
5
